Beta Bionics, Inc. (BBNX) vs Odyssey Therapeutics, Inc. (ODTX)
A side-by-side comparison of Beta Bionics, Inc. and Odyssey Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ODTX
Odyssey Therapeutics, Inc.
$18.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BBNX vs ODTX
growth of $100 · dividends reinvested · last 1yBBNX +96.4% (+96.4%/yr)ODTX +26.9% (+26.9%/yr)BBNX compounded faster over this window
BBNX ODTX
BBNX vs ODTX: by the numbers
- •ODTX is the larger company ($871M vs $838M market cap).
- •Both run net losses; BBNX's is the smaller (-61.32% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | BBNX | ODTX |
|---|---|---|
| P/S ratio | 7.04 | N/A |
| P/B ratio | 3.27 | 2.07 |
Profitability
| Metric | BBNX | ODTX |
|---|---|---|
| Gross margin | 58.31% | 100.00% |
| Operating margin | -69.75% | -5415.19% |
| Net margin | -61.32% | -4994.86% |
| ROE | -28.46% | N/A |
| ROIC | -31.17% | -66.23% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.